S. Joffe and J. Weeks, Views of American Oncologists About the Purposes of Clinical Trials, JNCI Journal of the National Cancer Institute, vol.94, issue.24, pp.1847-1853, 2002.
DOI : 10.1093/jnci/94.24.1847

O. Brawley, The Study of Accrual to Clinical Trials: Can We Learn From Studying Who Enters Our Studies?, Journal of Clinical Oncology, vol.22, issue.11, pp.2039-2040, 2004.
DOI : 10.1200/JCO.2004.02.926

P. Castel, S. Négrier, and J. Boissel, Why don???t cancer patients enter clinical trials? A review, European Journal of Cancer, vol.42, issue.12, pp.1744-1748, 2006.
DOI : 10.1016/j.ejca.2005.10.033

P. Castel and S. Dalgalarrondo, Freins et moteurs à la participation des cliniciens et à l'inclusion des patients dans les essais cliniques multicentriques. Plateforme d'Aide à la Recherche Clinique en Cancérologie

I. Baszanger, Entre traitement de la dernière chance et palliatif pur : les frontières invisibles des innovations thérapeutiques. Sciences sociales et santé, pp.67-94, 2000.

K. Taylor, Integrating conflicting professional roles: Physician participation in randomized clinical trials, Social Science & Medicine, vol.35, issue.2, pp.217-224, 1992.
DOI : 10.1016/0277-9536(92)90169-Q

P. Ellis, P. Butow, and M. Tattersall, Randomized Clinical Trials in Oncology: Understanding and Attitudes Predict Willingness to Participate, Journal of Clinical Oncology, vol.19, issue.15, pp.3554-3561, 2001.
DOI : 10.1200/JCO.2001.19.15.3554

P. Ellis, P. Butow, and M. Tattersall, Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet, Annals of Oncology, vol.13, issue.9, pp.1414-1423, 2002.
DOI : 10.1093/annonc/mdf255

N. Meropol, K. Weinfurt, and C. Burnett, Perceptions of Patients and Physicians Regarding Phase I Cancer Clinical Trials: Implications for Physician-Patient Communication, Journal of Clinical Oncology, vol.21, issue.13, pp.2589-2596, 2003.
DOI : 10.1200/JCO.2003.10.072